OrbiMed’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-389,500
| Closed | -$100M | – | 152 |
|
|
2021
Q4 | $100M | Buy |
389,500
+195,700
| +101% | +$47.9M | 1.29% | 28 |
|
|
2021
Q3 | $47M | Buy |
+193,800
| New | +$47.4M | 0.52% | 53 |
|
|
2020
Q2 | – | Sell |
-709,800
| Closed | -$63.8M | – | 143 |
|
|
2020
Q1 | $63.8M | Buy |
709,800
+519,800
| +274% | +$67.3M | 1.07% | 32 |
|
|
2019
Q4 | $28.1M | Buy |
+190,000
| New | +$25.5M | 0.4% | 57 |
|
|
2019
Q1 | – | Sell |
-75,900
| Closed | -$9.45M | – | 134 |
|
|
2018
Q4 | $9.45M | Hold |
75,900
| – | – | 0.17% | 87 |
|
|
2018
Q3 | $10.6M | Sell |
75,900
-161,400
| -68% | -$20.1M | 0.13% | 111 |
|
|
2018
Q2 | $24.3M | Sell |
237,300
-245,100
| -51% | -$24.8M | 0.29% | 78 |
|
|
2018
Q1 | $46.8M | Buy |
+482,400
| New | +$46.8M | 0.58% | 51 |
|
|
2017
Q4 | – | Sell |
-187,400
| Closed | -$14.9M | – | 138 |
|
|
2017
Q3 | $14.9M | Sell |
187,400
-410,000
| -69% | -$33M | 0.14% | 95 |
|
|
2017
Q2 | $52.1M | Sell |
597,400
-1,147,600
| -66% | -$97.1M | 0.55% | 55 |
|
|
2017
Q1 | $155M | Sell |
1,745,000
-257,200
| -13% | -$21.4M | 1.76% | 16 |
|
|
2016
Q4 | $148M | Buy |
2,002,200
+690,000
| +53% | +$51.7M | 1.89% | 17 |
|
|
2016
Q3 | $99.2M | Sell |
1,312,200
-2,786,100
| -68% | -$213M | 1.13% | 31 |
|
|
2016
Q2 | $316M | Sell |
4,098,300
-1,638,800
| -29% | -$129M | 3.29% | 7 |
|
|
2016
Q1 | $448M | Sell |
5,737,100
-218,500
| -4% | -$15.3M | 4.71% | 2 |
|
|
2015
Q4 | $403M | Buy |
5,955,600
+117,700
| +2% | +$8.21M | 3.65% | 9 |
|
|
2015
Q3 | $452M | Buy |
5,837,900
+820,500
| +16% | +$72.7M | 4.56% | 2 |
|
|
2015
Q2 | $455M | Buy |
5,017,400
+609,400
| +14% | +$48.8M | 3.8% | 4 |
|
|
2015
Q1 | $332M | Buy |
4,408,000
+100,000
| +2% | +$7.18M | 2.83% | 7 |
|
|
2014
Q4 | $316M | Buy |
4,308,000
+95,000
| +2% | +$6.68M | 3.02% | 8 |
|
|
2014
Q3 | $297M | Sell |
4,213,000
-300,000
| -7% | -$19.8M | 3.1% | 10 |
|
|
2014
Q2 | $254M | Buy |
4,513,000
+298,000
| +7% | +$15.7M | 2.99% | 8 |
|
|
2014
Q1 | $221M | Buy |
4,215,000
+457,000
| +12% | +$22.7M | 2.72% | 9 |
|
|
2013
Q4 | $179M | Buy |
3,758,000
+705,000
| +23% | +$32.6M | 2.64% | 12 |
|
|
2013
Q3 | $131M | Sell |
3,053,000
-313,300
| -9% | -$12.2M | 2.33% | 13 |
|
|
2013
Q2 | $121M | Buy |
+3,366,300
| New | +$130M | 2.57% | 12 |
|
Other funds holding HCA
OrbiMed's HCA Position: Q1 2022 in Review
OrbiMed sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 389,500 shares — an estimated $100M sold.
OrbiMed first reported a position in HCA in Q2 2013 and held it in 26 quarters. The position peaked at $455M in Q2 2015. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.
- OrbiMed reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
- OrbiMed sold 389,500 HCA Healthcare shares in Q1 2022, an estimated $100M.
- OrbiMed first reported a position in HCA Healthcare in Q2 2013 and held it in 26 quarters.
- OrbiMed's HCA Healthcare position peaked at $455M in Q2 2015.
- 968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.
Based on OrbiMed's 13F filing for Q1 2022, filed 16 May 2022.